CANCER AND PREGNANCY


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Recently, women have delayed childbirth until they achieve their professional carrier so its rate after the age of 30 years increases significantly, which is associated with more frequently diagnosed cancer during pregnancy. It has long been considered that pregnancy must be interrupted when a malignant disease is diagnosed during pregnancy, but recent investigations have indicated that appropriate treatment may be performed during pregnancy in most cases, without jeopardizing the life of the mother and fetus. The review describes the controversial issues of diagnosis, treatment and management using chemotherapy during pregnancy.

Full Text

Restricted Access

About the authors

W. A PAUCKER

Hospital of Bremen Nord

Email: www.wladimir.pauker@klinikum-bremen-nord.de

R. G SHMAKOV

Academician V.I. Kulakov Research Center of Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia

Email: mdshmakov@mail.ru

References

  1. Byrd B.F.Jr., Bayer D.S., Robertson J.C., Stephenson S.E.Jr. Treatment of breast tumors associated with pregnancy and lactation. Ann. Surg. 1962; 155(6): 940-7.
  2. Creskoff A., Fitz-Hugh T.J., Frost J. Urethane therapy in leukemia. Blood. 1948; 3: 896-910.
  3. Bolling C., Schuster S., Pfeiffer J. Hematological and non-gynecological malignancies in pregnancy. Treatment options, problems and challenges. Gynakologe. 2012; 45(12): 951-8.
  4. Van Calsteren K., Heyns L., De Smet F., Van Eycken L., Gziri M.M., Van Gemert W et al. Cancer during pregnancy: an analysis of 215 patients emphasizing the obstetrical and the neonatal outcomes. J. Clin. Oncol. 2010; 28(4): 683-9.
  5. Serkies K., Wegrzynowicz E., Jasem J. Paclitaxel and cisplatin chemotherapy for ovarian cancer during pregnancy: case report and review of the literature. Arch. Gynecol. Obstet. 2011; 283(1): 97-100.
  6. Mir O., Berveiller P., Goffinet F., Treluyer J.M., Serreau R., Goldwasser F., Rouzier R Taxanes for breast cancer during pregnancy: a systematic review. Ann. Oncol. 2010; 21(2): 425-6.
  7. Stensheim H., M0ller B., van Dijk T., Fossa S.D. Cause-specific survival for women diagnosed with cancer during pregnancy or lactation: A registry-based cohort study. J. Clin. Oncol. 2009; 27(1): 45-51.
  8. Hahn K.M., Johnson P.H., Gordon N., Kuerer H., Middleton L., Ramirez M. et al. Treatment of pregnant breast cancer patients and outcomes of children exposed to chemotherapy in utero. Cancer. 2006; 107(6): 1219-26.
  9. Abdel-Hady E.-S., Hemida R.A.-H., Gamal A., El-Zafarany M., Toson E., El-Bayoumi M.A. Cancer during pregnancy: perinatal outcome after in utero exposure to chemotherapy. Arch. Gynecol. Obstet. 2012; 286(2): 283-6.
  10. Amant F., Van Calsteren K., Halaska M.J., Gziri M.M., Hui W., Lagae L. et al. Long-term cognitive and cardiac outcomes after prenatal exposure to chemotherapy in children aged 18 months or older: an observational study. Lancet Oncol. 2012; 13(3): 256-64.
  11. Hasenburg A., Rautenberg B. Gynecological cancer during pregnancy. Onkologe. 2012; 18(4): 330-7.
  12. https://www.destatis.de/DE/ZahlenFakten/GesellschaftStaat/ Bevoelkerung/Geburten/Tabellen/LebendgeboreneAlter.html
  13. Haas J.F. Pregnancy in association with a newly diagnosed cancer: A population-based epidemiology assessment. Int. J. Cancer. 1984; 34(2): 229-35.
  14. Hoellen F., Reibke R., Hornemann K., Thill M., Luedders D.W., Kelling K. et al. Cancer in pregnancy. Part I: basic diagnostic and therapeutic principles and treatment of gynecological malignancies. Arch. Gynecol. Obstet. 2012; 285(1): 195-205.
  15. Albrektsen G., Heuch I., Thoresen S., Kvale G. Clinical stage of breast cancer by parity, age at birth, and time since birth: a progressive effect of pregnancy hormones? Cancer Epidemiol. Biomarkers Prev. 2006; 15(1): 65-9.
  16. Cardonick E., Dougherty R., Grana G., Gilmandyar D., Ghaffar S., Usmani A. Breast cancer during pregnancy: Maternal and fetal outcomes. Cancer J. 2010; 16(1): 76-82.
  17. Morice P., Uzan C., Gouy S., Verschraegen C., Haie-Meder C. Gynaecological cancers during pregnancy. Lancet. 2012; 379(9815): 558-69.
  18. Han S.N., Kesic V.I., Van Calsteren K., Petkovic S., Amant F; ESGO 'Cancer in Pregnancy’ Task Force. Cancer in pregnancy: a survey of current clinical practice. Eur. J. Obstet. Gynecol. Reprod. Biol. 2013; 167(1): 18-23._
  19. Kroman N., Jensen M.-B., Wohlfahrt J., Ejlertsen B. Pregnancy after treatment of breast cancer - A population-based study on behalf of Danish Breast Cancer Cooperative Group. Acta Oncol. 2008; 47(4): 545-9.
  20. Pentheroudakis G., Pavlidis N. Cancer and pregnancy: poena magna, not anymore. Eur. J. Cancer. 2006; 42(2): 126-40.
  21. Wunderlich P., Zophel K. Diagnostic imaging in pregnancy. Onkologe. 2012; 18(4): 308-15.
  22. Schulze-Rath R., Hammer G.P., Blettner M. Are pre- or postnatal diagnostic X-rays a risk factor for childhood cancer? A systematic review. Radiat. Environ. Biophys. 2008; 47(1-3): 301-12.
  23. Helmrot E., Pettersson H., Sandborg M., Alten J.N. Estimation dose to the unborn child at diagnostic X-ray examinations based on data registered in RIS /PACS. Eur. Radiol. 2007; 17(1): 205-9.
  24. Ray J., Schull M., Urquia M., You J., Guttman A., Vermeulen M.J. Major radiodiagnostic imaging in pregnancy and the risk of childhood malignancy: A population-based cohort study in Ontario. PLoS Med. 2010; 7(9): e1000337.
  25. Valentin J. Effects of in utero irradiation. Ann. ICRP. 2000; 30: 9-12.
  26. Salvesen K.A. Epidemiological prenatal ultrasound studies. Prog. Biophys. Mol. Biol. 2007; 93(3): 295-300.
  27. Loibl S. Mammakarzinom in der Schwangerschaft. Interdisziplinares Vorgehen und Behandlungsoptionen. Gynakologie. 2010; 6: 8-12.
  28. Vashi R., Hooley R., Butler R., Geisel J., Philpotts L. Breast imaging of the pregnant and lactating patient: imaging modalities and pregnancy - associated breast cancer. AJR Am. J. Roentgenol. 2013; 200(2): 321-8.
  29. Kok R.D., de Vries M.M., Heerschap A., van den Berg P.P. Absence of harmful effects of magnetic resonance exposure at 1.5 T in utero during the third trimester of pregnancy: a follow-up study. Magn. Reson. Imaging. 2004; 22(6): 851-4.
  30. Reeves M.J., Brandreth M., Whitby E.H., Hart A.R., Paley M.N., Griffiths P.D., Stevens J.C. Neonatal cochlear function: measurement after exposure to acoustic noise during in utero MR imaging. Radiology. 2010; 257(3): 802-9.
  31. Frohlich J.M., Kubik-Huch R.A. Radiographic, MR or ultrasound contrast media in pregnant or breast-feeding women: What are the key issues? Fortschr. Rontgenstr. 2013; 185(1): 13-25.
  32. Interdisziplinare S3-Leitlinie fur Diagnostik, Therapie und Nachsorge des Mammakarzinoms. Munchen: Zuckschwerdt; 2012. 382s.
  33. Takalkar A.M., Khandelwal A., Lokitz S., Lilien D.L, Stabin M.G. 18F-FDG PET in pregnancy and fetal radiation dose estimates. J. Nucl. Med. 2011; 52(7): 1035-40.
  34. Stuschke M., Mtiller W.-U. Radiation therapy during pregnancy. Onkologe. 2012; 18(4): 316-29.
  35. Kal H.B., Struikmans H. Radiotherapy during pregnancy: fact and fiction. Lancet Oncol. 2005; 6(5): 328-33.
  36. Luis S.A., Christie D.R., Kaminski A., Kenny L., Peres M.H. Pregnancy and radiotherapy: Management options for minimising risk, case series and comprehensive literature review. J. Med. Imaging Radiat. Oncol. 2009; 53(6): 559-68.
  37. Voulgaris E., Pentheroudakis G., Pavlidis N. Cancer and pregnacy: A comprehensive review. Surg. Oncol. 2011; 20(4): 175-85.
  38. McGrath S.E., Ring A. Chemotherapy for breast cancer in pregnancy: evidence and guidance for oncologists. Ther. Adv. Med. Oncol. 2011; 3(2): 73-83.
  39. Heyns L., Van Calsteren K., Han S.N., Mhallem Gziri M., Augustijns P., Amant F. Chemotherapy during pregnancy. Belg. J. Hematol. 2011; 2(3): 101-6.
  40. Van Calsteren K., Verbesselt R., Ottevanger N., Halaska M., HeynsL., Van Bree R et al. Pharmacokinetics of chemotherapeutic agents in pregnancy: a preclinical and clinical study. Acta Obstet. Gynecol. Scand. 2010; 89(10): 1338-45.
  41. Parisi M.A., Spong C.Y., Zajicek A., Guttmacher A.E. We don’t know what we don’t study: The case for research on medication effects in pregnancy. Am. J. Med. Genet. Pt C. 2011; 157(3): 247-50.
  42. Andrade S.E., Gurwitz J.H., Davis R.L., Chan K.A., Finkelstein J.A., Fortman K. et al. Prescription drug use in pregnancy. Am. J. Obstet. Gynecol. 2004; 191(2): 398-407.
  43. Chambers C.D., Polifka J.E., Friedman J.M.Drug safety in pregnant women and their babies: ignorance not bliss. Clin. Pharmacol. Ther. 2008; 83(1): 181-3.
  44. Mitchell A.A., Gilboa S.M., Werler M.M., Kelley K.E., Louik C, Hernandez-Diaz S. Medication use during pregnancy, with particular focus on prescription drugs: 1976-2008. Am. J. Obstet. Gynecol. 2011; 205(1): 51-8.
  45. Brewer M., Kueck A., Runowicz C.D. Chemotherapy in pregnancy. Clin. Obstet. Gynecol. 2011; 54(4): 602-18.
  46. Aviles A., Neri N., Nambo M.J. Long-term evaluation of cardiac function in children who received anthracyclines during pregnancy. Ann. Oncol. 2006; 17(2): 286-8.
  47. Reynoso E.E., Shephard F.A., Messner H.A., Farquharson H.A., Garvey M.B., Baker M.A. Acute leukemia during pregnancy: The Toronto Leukemia Study Group experience with long-term follow-up of children exposed in utero to chemotherapeutic agent. J. Clin. Oncol. 1987; 5(7): 1098-106.
  48. Backes C.H., Moorehead P.A., Nelin L.D. Cancer in pregnancy: fetal and neonatal outcomes. Clin. Obstet. Gynecol. 2011; 54(4): 574-90.
  49. Marnitz S., Kohler C., Oppelt P., Schmittel A., Favero G., Hasenbein K. et al. Cisplatin application in pregnancy: first in vivo analysis of 7 patients. Oncology. 2010; 79(1-2): 72-7.
  50. Schafer A.I. Teratogenic effects of antileukemia chemotherapy. Arch. Intern. Med. 1981; 141: 514-5.
  51. Aviles A., Neri N., Nambo M.J. Hematological malignancies and pregnancy: Treat or no treat during first trimester. Int. J. Cancer. 2012; 131(11): 2678-83.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies